The updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus.
Women have higher risk for solicited reactions after flu shot
Sep 29, 2023
Women have a higher risk for injection site reactions, systemic reactions and severe reactions.
Just 23 percent of US adults ‘definitely’ plan to get new COVID-19 vaccine
Sep 27, 2023
Interest is highest among those aged 65 years and older (64%) and among Democrats (70%).
Flu vaccine uptake varies by sociodemographic factors in CKD patients
Sep 26, 2023
Just under three-quarters of patients with chronic kidney disease receive flu vaccines
CDC panel gives support to new COVID-19 booster shots
Sep 13, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Flu vaccine cut risk for influenza-linked hospitalizations in 2023
Sep 11, 2023
Interim data show vaccine effectiveness of 51.9% in five South American countries during their flu season.
Moderna says updated COVID-19 vaccine shields against highly mutated new variant
Sep 06, 2023
Scientists found that the variant appears to be less concerning than initially thought, with data showing that it is 60% less infectious than XBB.1.5 variants.
Updated COVID-19 vaccines will roll out mid-September, officials say
Aug 25, 2023
The new vaccines will target the XBB.1.5 coronavirus subvariant and offer some protection for closely related strains.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
FDA approves first RSV vaccine
May 03, 2023
Arexvy was ~82% effective in preventing RSV-induced lower respiratory tract infections in adults aged 60 or more years.